Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1347 entries
Sorted by: Best Match Show Resources per page
Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel.

Case reports in oncological medicine

Benbrahim Z, Arifi S, Benhammane H, Inani K, Gallouj S, Meziane M, Mernissi FZ, Mellas N, El Mesbahi O.
PMID: 23476845
Case Rep Oncol Med. 2013;2013:196878. doi: 10.1155/2013/196878. Epub 2013 Feb 14.

Classic Kaposi's sarcoma (CKS) is a subtype that traditionally occurs in elderly HIV-negative males of Mediterranean origin. Patients with CKS characteristically present with skin lesions in the distal extremities. Involvement of the viscera is uncommon but may occur in...

Cite
Benbrahim Z, Arifi S, Benhammane H, et al. Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel. Case Rep Oncol Med. 2013;2013:196878doi: 10.1155/2013/196878.
Benbrahim, Z., Arifi, S., Benhammane, H., Inani, K., Gallouj, S., Meziane, M., Mernissi, F. Z., Mellas, N., & El Mesbahi, O. (2013). Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel. Case reports in oncological medicine, 2013196878. https://doi.org/10.1155/2013/196878
Benbrahim, Zineb, et al. "Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel." Case reports in oncological medicine vol. 2013 (2013): 196878. doi: https://doi.org/10.1155/2013/196878
Benbrahim Z, Arifi S, Benhammane H, Inani K, Gallouj S, Meziane M, Mernissi FZ, Mellas N, El Mesbahi O. Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel. Case Rep Oncol Med. 2013;2013:196878. doi: 10.1155/2013/196878. Epub 2013 Feb 14. PMID: 23476845; PMCID: PMC3586472.
Copy Download .nbib Format: NLM
Effects of artichoke (Cynara scolymus) leaf and bloom head extracts on chemically induced DNA lesions in Drosophila melanogaster.

Genetics and molecular biology

Jacociunas LV, Dihl RR, Lehmann M, de Barros Falcão Ferraz A, Richter MF, da Silva J, de Andrade HH.
PMID: 24688296
Genet Mol Biol. 2014 Mar;37(1):90-104. doi: 10.1590/s1415-47572014000100015. Epub 2013 Feb 28.

The genotoxicity of bloom head (BHE) and leaf (LE) extracts from artichoke (Cynara scolymus L.), and their ability to modulate the mutagenicity and recombinogenicity of two alkylating agents (ethyl methanesulfonate - EMS and mitomycin C - MMC) and the...

Cite
Jacociunas LV, Dihl RR, Lehmann M, et al. Effects of artichoke (Cynara scolymus) leaf and bloom head extracts on chemically induced DNA lesions in Drosophila melanogaster. Genet Mol Biol. 2013;37(1):90-104doi: 10.1590/s1415-47572014000100015.
Jacociunas, L. V., Dihl, R. R., Lehmann, M., de Barros Falcão Ferraz, A., Richter, M. F., da Silva, J., & de Andrade, H. H. (2014). Effects of artichoke (Cynara scolymus) leaf and bloom head extracts on chemically induced DNA lesions in Drosophila melanogaster. Genetics and molecular biology, 37(1), 90-104. https://doi.org/10.1590/s1415-47572014000100015
Jacociunas, Laura Vicedo, et al. "Effects of artichoke (Cynara scolymus) leaf and bloom head extracts on chemically induced DNA lesions in Drosophila melanogaster." Genetics and molecular biology vol. 37,1 (2014): 90-104. doi: https://doi.org/10.1590/s1415-47572014000100015
Jacociunas LV, Dihl RR, Lehmann M, de Barros Falcão Ferraz A, Richter MF, da Silva J, de Andrade HH. Effects of artichoke (Cynara scolymus) leaf and bloom head extracts on chemically induced DNA lesions in Drosophila melanogaster. Genet Mol Biol. 2014 Mar;37(1):90-104. doi: 10.1590/s1415-47572014000100015. Epub 2013 Feb 28. PMID: 24688296; PMCID: PMC3958332.
Copy Download .nbib Format: NLM
Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole.

Gynecologic oncology reports

Gorski JW, Taylor JS, Zhang J, Liu J, Jazaeri AA.
PMID: 28393092
Gynecol Oncol Rep. 2017 Mar 14;20:93-96. doi: 10.1016/j.gore.2017.03.005. eCollection 2017 May.

OBJECTIVE: Ovarian anaplastic ependymoma is a rare gynecologic malignancy that poses diagnostic and treatment challenges. Treatment of sub-optimally debulked disease usually portends poor prognosis. Molecular testing of tumor specimen can identify more specific targets for additional therapy such as...

Cite
Gorski JW, Taylor JS, Zhang J, et al. Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecol Oncol Rep. 2017;20:93-96doi: 10.1016/j.gore.2017.03.005.
Gorski, J. W., Taylor, J. S., Zhang, J., Liu, J., & Jazaeri, A. A. (2017). Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecologic oncology reports, 2093-96. https://doi.org/10.1016/j.gore.2017.03.005
Gorski, Justin Wayne, et al. "Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole." Gynecologic oncology reports vol. 20 (2017): 93-96. doi: https://doi.org/10.1016/j.gore.2017.03.005
Gorski JW, Taylor JS, Zhang J, Liu J, Jazaeri AA. Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole. Gynecol Oncol Rep. 2017 Mar 14;20:93-96. doi: 10.1016/j.gore.2017.03.005. eCollection 2017 May. PMID: 28393092; PMCID: PMC5376265.
Copy Download .nbib Format: NLM
Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.

PloS one

Andrade-Sousa AS, Rogério Pereira P, MacKenzie B, Oliveira-Junior MC, Assumpção-Neto E, Brandão-Rangel MA, Damaceno-Rodrigues NR, Garcia Caldini E, Velosa AP, Teodoro WR, Ligeiro de Oliveira AP, Dolhnikoff M, Eickelberg O, Vieira RP.
PMID: 27677175
PLoS One. 2016 Sep 27;11(9):e0163420. doi: 10.1371/journal.pone.0163420. eCollection 2016.

INTRODUCTION: The aim of this study was to investigate the effect of aerobic exercise (AE) in reducing bleomycin-induced fibrosis in mice of a Th2-dominant immune background (BALB/c).METHODS: BALB/c mice were distributed into: sedentary, control (CON), Exercise-only (EX), sedentary, bleomycin-treated...

Cite
Andrade-Sousa AS, Rogério Pereira P, MacKenzie B, et al. Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice. PLoS One. 2016;11(9):e0163420doi: 10.1371/journal.pone.0163420.
Andrade-Sousa, A. S., Rogério Pereira, P., MacKenzie, B., Oliveira-Junior, M. C., Assumpção-Neto, E., Brandão-Rangel, M. A., Damaceno-Rodrigues, N. R., Garcia Caldini, E., Velosa, A. P., Teodoro, W. R., Ligeiro de Oliveira, A. P., Dolhnikoff, M., Eickelberg, O., & Vieira, R. P. (2016). Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice. PloS one, 11(9), e0163420. https://doi.org/10.1371/journal.pone.0163420
Andrade-Sousa, Adilson Santos, et al. "Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice." PloS one vol. 11,9 (2016): e0163420. doi: https://doi.org/10.1371/journal.pone.0163420
Andrade-Sousa AS, Rogério Pereira P, MacKenzie B, Oliveira-Junior MC, Assumpção-Neto E, Brandão-Rangel MA, Damaceno-Rodrigues NR, Garcia Caldini E, Velosa AP, Teodoro WR, Ligeiro de Oliveira AP, Dolhnikoff M, Eickelberg O, Vieira RP. Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice. PLoS One. 2016 Sep 27;11(9):e0163420. doi: 10.1371/journal.pone.0163420. eCollection 2016. PMID: 27677175; PMCID: PMC5038953.
Copy Download .nbib Format: NLM
Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.

Fibrogenesis & tissue repair

Miguel V, Busnadiego O, Fierro-Fernández M, Lamas S.
PMID: 27274768
Fibrogenesis Tissue Repair. 2016 May 10;9:7. doi: 10.1186/s13069-016-0044-2. eCollection 2016.

BACKGROUND: Excessive accumulation of extracellular matrix (ECM) proteins is the hallmark of fibrotic diseases, including skin fibrosis. This response relies on the activation of dermal fibroblasts that evolve into a pro-fibrogenic phenotype. One of the major players in this...

Cite
Miguel V, Busnadiego O, Fierro-Fernández M, et al. Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair. 2016;9:7doi: 10.1186/s13069-016-0044-2.
Miguel, V., Busnadiego, O., Fierro-Fernández, M., & Lamas, S. (2016). Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis & tissue repair, 97. https://doi.org/10.1186/s13069-016-0044-2
Miguel, Verónica, et al. "Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts." Fibrogenesis & tissue repair vol. 9 (2016): 7. doi: https://doi.org/10.1186/s13069-016-0044-2
Miguel V, Busnadiego O, Fierro-Fernández M, Lamas S. Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair. 2016 May 10;9:7. doi: 10.1186/s13069-016-0044-2. eCollection 2016. PMID: 27274768; PMCID: PMC4891847.
Copy Download .nbib Format: NLM
Bleomycin-induced flagellate erythema: A case report and review of the literature.

Oncology letters

Lee HY, Lim KH, Ryu Y, Song SY.
PMID: 25009666
Oncol Lett. 2014 Aug;8(2):933-935. doi: 10.3892/ol.2014.2179. Epub 2014 May 26.

Bleomycin has been used most commonly in the treatment of Hodgkin's lymphoma, certain germ cell tumors (GCT) and for the sclerosis of recurrent pleural effusions. Bleomycin toxicity predominantly affects the skin and lungs. Skin toxicity includes Raynaud's phenomenon, hyperkeratosis,...

Cite
Lee HY, Lim KH, Ryu Y, et al. Bleomycin-induced flagellate erythema: A case report and review of the literature. Oncol Lett. 2014;8(2):933-935doi: 10.3892/ol.2014.2179.
Lee, H. Y., Lim, K. H., Ryu, Y., & Song, S. Y. (2014). Bleomycin-induced flagellate erythema: A case report and review of the literature. Oncology letters, 8(2), 933-935. https://doi.org/10.3892/ol.2014.2179
Lee, Hui-Young, et al. "Bleomycin-induced flagellate erythema: A case report and review of the literature." Oncology letters vol. 8,2 (2014): 933-935. doi: https://doi.org/10.3892/ol.2014.2179
Lee HY, Lim KH, Ryu Y, Song SY. Bleomycin-induced flagellate erythema: A case report and review of the literature. Oncol Lett. 2014 Aug;8(2):933-935. doi: 10.3892/ol.2014.2179. Epub 2014 May 26. PMID: 25009666; PMCID: PMC4081419.
Copy Download .nbib Format: NLM
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.

Physiological reports

Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F.
PMID: 26660549
Physiol Rep. 2015 Dec;3(12). doi: 10.14814/phy2.12628.

Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. Inflammation plays an integral role in the development of pulmonary fibrosis. Unresolved inflammatory responses can lead to substantial tissue injury, chronic inflammation, and fibrosis. The resolvins...

Cite
Yatomi M, Hisada T, Ishizuka T, et al. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep. 2015;3(12)doi: 10.14814/phy2.12628.
Yatomi, M., Hisada, T., Ishizuka, T., Koga, Y., Ono, A., Kamide, Y., Seki, K., Aoki-Saito, H., Tsurumaki, H., Sunaga, N., Kaira, K., Dobashi, K., Yamada, M., & Okajima, F. (2015). 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiological reports, 3(12), . https://doi.org/10.14814/phy2.12628
Yatomi, Masakiyo, et al. "17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice." Physiological reports vol. 3,12 (2015). doi: https://doi.org/10.14814/phy2.12628
Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep. 2015 Dec;3(12). doi: 10.14814/phy2.12628. PMID: 26660549; PMCID: PMC4760456.
Copy Download .nbib Format: NLM
Bleomycin-induced flagellate dermatitis.

Revista brasileira de hematologia e hemoterapia

Mota GD, Penna AM, Soares RC, Baiocchi OC.
PMID: 25031171
Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):297-9. doi: 10.1016/j.bjhh.2014.03.001. Epub 2014 Apr 03.

A 29-year-old woman with stage IVB Hodgkin's lymphoma was treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. Two weeks after the first cycle was completed, she developed pruritic, linear erythematous lesions in a flagellate-like pattern on the trunk, neck and...

Cite
Mota GD, Penna AM, Soares RC, et al. Bleomycin-induced flagellate dermatitis. Rev Bras Hematol Hemoter. 2014;36(4):297-9doi: 10.1016/j.bjhh.2014.03.001.
Mota, G. D., Penna, A. M., Soares, R. C., & Baiocchi, O. C. (2014). Bleomycin-induced flagellate dermatitis. Revista brasileira de hematologia e hemoterapia, 36(4), 297-9. https://doi.org/10.1016/j.bjhh.2014.03.001
Mota, Guilherme Devidé, et al. "Bleomycin-induced flagellate dermatitis." Revista brasileira de hematologia e hemoterapia vol. 36,4 (2014): 297-9. doi: https://doi.org/10.1016/j.bjhh.2014.03.001
Mota GD, Penna AM, Soares RC, Baiocchi OC. Bleomycin-induced flagellate dermatitis. Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):297-9. doi: 10.1016/j.bjhh.2014.03.001. Epub 2014 Apr 03. PMID: 25031171; PMCID: PMC4207924.
Copy Download .nbib Format: NLM
Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168].

Ultrasonics sonochemistry

Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.
PMID: 27291696
Ultrason Sonochem. 2017 Sep;38:751. doi: 10.1016/j.ultsonch.2016.06.002. Epub 2016 Jun 09.

No abstract available.

Cite
Osaki T, Yokoe I, Uto Y, et al. Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrason Sonochem. 2016;38:751doi: 10.1016/j.ultsonch.2016.06.002.
Osaki, T., Yokoe, I., Uto, Y., Ishizuka, M., Tanaka, T., Yamanaka, N., Kurahashi, T., Azuma, K., Murahata, Y., Tsuka, T., Ito, N., Imagawa, T., & Okamoto, Y. (2017). Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrasonics sonochemistry, 38751. https://doi.org/10.1016/j.ultsonch.2016.06.002
Osaki, Tomohiro, et al. "Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]." Ultrasonics sonochemistry vol. 38 (2017): 751. doi: https://doi.org/10.1016/j.ultsonch.2016.06.002
Osaki T, Yokoe I, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y. Corrigendum to "Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate" [Ultrason. Sonochem. 28 (2016) 161-168]. Ultrason Sonochem. 2017 Sep;38:751. doi: 10.1016/j.ultsonch.2016.06.002. Epub 2016 Jun 09. PMID: 27291696.
Copy Download .nbib Format: NLM
Unusual primary osseous Hodgkin's lymphoma: A case report.

Oncology letters

Luo W, Zhang F, Sun J, He H.
PMID: 25621037
Oncol Lett. 2015 Feb;9(2):677-680. doi: 10.3892/ol.2014.2724. Epub 2014 Nov 20.

Hodgkin's lymphoma (HL) is one of the few adult malignancies that most frequently presents with a progressive, painless enlargement of the peripheral lymph nodes. A primary osseous presentation of HL, without lymph node involvement, is extremely rare. The present...

Cite
Luo W, Zhang F, Sun J, et al. Unusual primary osseous Hodgkin's lymphoma: A case report. Oncol Lett. 2014;9(2):677-680doi: 10.3892/ol.2014.2724.
Luo, W., Zhang, F., Sun, J., & He, H. (2015). Unusual primary osseous Hodgkin's lymphoma: A case report. Oncology letters, 9(2), 677-680. https://doi.org/10.3892/ol.2014.2724
Luo, Wei, et al. "Unusual primary osseous Hodgkin's lymphoma: A case report." Oncology letters vol. 9,2 (2015): 677-680. doi: https://doi.org/10.3892/ol.2014.2724
Luo W, Zhang F, Sun J, He H. Unusual primary osseous Hodgkin's lymphoma: A case report. Oncol Lett. 2015 Feb;9(2):677-680. doi: 10.3892/ol.2014.2724. Epub 2014 Nov 20. PMID: 25621037; PMCID: PMC4301495.
Copy Download .nbib Format: NLM
Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An .

Oncology letters

Chiaravalloti A, Pagani M, Cantonetti M, DI Pietro B, Tavolozza M, Travascio L, DI Biagio D, Danieli R, Schillaci O.
PMID: 25621038
Oncol Lett. 2015 Feb;9(2):685-690. doi: 10.3892/ol.2014.2765. Epub 2014 Dec 03.

The aim of the present study was to investigate brain glucose metabolism in patients with Hodgkin disease (HD) after diagnosis and during chemotherapy treatment. Following the administration of first-line doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy, 74 HD patients...

Cite
Chiaravalloti A, Pagani M, Cantonetti M, et al. Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncol Lett. 2014;9(2):685-690doi: 10.3892/ol.2014.2765.
Chiaravalloti, A., Pagani, M., Cantonetti, M., DI Pietro, B., Tavolozza, M., Travascio, L., DI Biagio, D., Danieli, R., & Schillaci, O. (2015). Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncology letters, 9(2), 685-690. https://doi.org/10.3892/ol.2014.2765
Chiaravalloti, Agostino, et al. "Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An ." Oncology letters vol. 9,2 (2015): 685-690. doi: https://doi.org/10.3892/ol.2014.2765
Chiaravalloti A, Pagani M, Cantonetti M, DI Pietro B, Tavolozza M, Travascio L, DI Biagio D, Danieli R, Schillaci O. Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncol Lett. 2015 Feb;9(2):685-690. doi: 10.3892/ol.2014.2765. Epub 2014 Dec 03. PMID: 25621038; PMCID: PMC4301514.
Copy Download .nbib Format: NLM
HPV Carcinomas in Immunocompromised Patients.

Journal of clinical medicine

Reusser NM, Downing C, Guidry J, Tyring SK.
PMID: 26239127
J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260.

Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide and can result in pre-malignancies or overt malignancies of the skin and mucosal surfaces. HPV-related illnesses are an important personal and public health problem causing physical, mental,...

Cite
Reusser NM, Downing C, Guidry J, et al. HPV Carcinomas in Immunocompromised Patients. J Clin Med. 2015;4(2):260-81doi: 10.3390/jcm4020260.
Reusser, N. M., Downing, C., Guidry, J., & Tyring, S. K. (2015). HPV Carcinomas in Immunocompromised Patients. Journal of clinical medicine, 4(2), 260-81. https://doi.org/10.3390/jcm4020260
Reusser, Nicole M, et al. "HPV Carcinomas in Immunocompromised Patients." Journal of clinical medicine vol. 4,2 (2015): 260-81. doi: https://doi.org/10.3390/jcm4020260
Reusser NM, Downing C, Guidry J, Tyring SK. HPV Carcinomas in Immunocompromised Patients. J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260. PMID: 26239127; PMCID: PMC4470124.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1347 entries